CY1106126T1 - Μεθοδος δια την παρασκευην ενωσεων 2-(4-αλκυλο-1-πιπepαζινυλο)-βενζαλδεϋδης και-βενζυλιδενυλιου δια νουκλεοφιλικης αρωματικης υποκαταστασεως 2-φθοροβενζαλδεϋδης δια 4-αλκυλο-1-πιπepαζινης, εις υδωρ ως διαλυτην - Google Patents

Μεθοδος δια την παρασκευην ενωσεων 2-(4-αλκυλο-1-πιπepαζινυλο)-βενζαλδεϋδης και-βενζυλιδενυλιου δια νουκλεοφιλικης αρωματικης υποκαταστασεως 2-φθοροβενζαλδεϋδης δια 4-αλκυλο-1-πιπepαζινης, εις υδωρ ως διαλυτην

Info

Publication number
CY1106126T1
CY1106126T1 CY20061101030T CY061101030T CY1106126T1 CY 1106126 T1 CY1106126 T1 CY 1106126T1 CY 20061101030 T CY20061101030 T CY 20061101030T CY 061101030 T CY061101030 T CY 061101030T CY 1106126 T1 CY1106126 T1 CY 1106126T1
Authority
CY
Cyprus
Prior art keywords
alkyl
pipepazinyl
pipepazine
benzylidenyl
fluorobenzaldehyde
Prior art date
Application number
CY20061101030T
Other languages
English (en)
Inventor
Joseph Philip Rainville
Terry Gene Sinay Jr.
Stanley Walter Walinsky
Original Assignee
Pfizer Products Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Incorporated filed Critical Pfizer Products Incorporated
Publication of CY1106126T1 publication Critical patent/CY1106126T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Μέθοδος δια την παρασκευήν ενώσεως του τύπου I:
CY20061101030T 2001-08-30 2006-07-25 Μεθοδος δια την παρασκευην ενωσεων 2-(4-αλκυλο-1-πιπepαζινυλο)-βενζαλδεϋδης και-βενζυλιδενυλιου δια νουκλεοφιλικης αρωματικης υποκαταστασεως 2-φθοροβενζαλδεϋδης δια 4-αλκυλο-1-πιπepαζινης, εις υδωρ ως διαλυτην CY1106126T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31601001P 2001-08-30 2001-08-30

Publications (1)

Publication Number Publication Date
CY1106126T1 true CY1106126T1 (el) 2011-06-08

Family

ID=23227067

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101030T CY1106126T1 (el) 2001-08-30 2006-07-25 Μεθοδος δια την παρασκευην ενωσεων 2-(4-αλκυλο-1-πιπepαζινυλο)-βενζαλδεϋδης και-βενζυλιδενυλιου δια νουκλεοφιλικης αρωματικης υποκαταστασεως 2-φθοροβενζαλδεϋδης δια 4-αλκυλο-1-πιπepαζινης, εις υδωρ ως διαλυτην

Country Status (24)

Country Link
US (1) US6608195B2 (el)
EP (1) EP1288208B1 (el)
JP (1) JP3902751B2 (el)
KR (1) KR100503518B1 (el)
CN (1) CN1172920C (el)
AR (1) AR036373A1 (el)
AT (1) ATE332897T1 (el)
AU (1) AU2002300770B2 (el)
BR (1) BR0203426A (el)
CA (1) CA2399970A1 (el)
CY (1) CY1106126T1 (el)
DE (1) DE60213043T2 (el)
DK (1) DK1288208T3 (el)
ES (1) ES2266416T3 (el)
HK (1) HK1051190A1 (el)
HU (1) HUP0202907A3 (el)
IL (1) IL151430A0 (el)
MX (1) MXPA02008538A (el)
PL (1) PL355799A1 (el)
PT (1) PT1288208E (el)
RU (1) RU2222533C1 (el)
TW (1) TWI234563B (el)
YU (1) YU62302A (el)
ZA (1) ZA200206888B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
WO2005113526A2 (en) * 2004-05-21 2005-12-01 Pfizer Products Inc. Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
CN111269585B (zh) * 2020-03-11 2021-10-08 苏州根岸生物科技有限责任公司 一种荧光染料及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56185C2 (uk) * 1996-09-30 2003-05-15 Пфайзер Інк. Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
US6248888B1 (en) * 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
TW426667B (en) 1997-11-19 2001-03-21 Pfizer Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists

Also Published As

Publication number Publication date
HU0202907D0 (el) 2002-10-28
US6608195B2 (en) 2003-08-19
YU62302A (sh) 2005-03-15
BR0203426A (pt) 2003-05-13
JP3902751B2 (ja) 2007-04-11
DK1288208T3 (da) 2006-10-16
RU2222533C1 (ru) 2004-01-27
EP1288208B1 (en) 2006-07-12
CA2399970A1 (en) 2003-02-28
TWI234563B (en) 2005-06-21
HK1051190A1 (en) 2003-07-25
KR100503518B1 (ko) 2005-07-25
US20030087914A1 (en) 2003-05-08
MXPA02008538A (es) 2003-03-05
JP2003096060A (ja) 2003-04-03
ES2266416T3 (es) 2007-03-01
RU2002123289A (ru) 2004-03-10
EP1288208A1 (en) 2003-03-05
PL355799A1 (en) 2003-03-10
AR036373A1 (es) 2004-09-01
PT1288208E (pt) 2006-09-29
ZA200206888B (en) 2004-03-01
IL151430A0 (en) 2003-04-10
CN1172920C (zh) 2004-10-27
DE60213043D1 (de) 2006-08-24
HUP0202907A2 (hu) 2003-06-28
KR20030019190A (ko) 2003-03-06
HUP0202907A3 (en) 2004-06-28
AU2002300770B2 (en) 2007-06-07
ATE332897T1 (de) 2006-08-15
CN1403448A (zh) 2003-03-19
DE60213043T2 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
SI1781683T1 (sl) Postopek za pripravo 17-vinil-triflatov kot intermediatov
MX2010001773A (es) Metodo para preparar derivados de 5-haloalquil-4,5-dihidroisoxasol .
GB0418900D0 (en) Novel salt forms
HK1088597A1 (en) Method for the production of substituted 3-aryl-butyl amine compounds
MXPA05008705A (es) Derivados de piridina como compuestos fungicidas.
BR0212185A (pt) Compostos e métodos para a preparação de compostos
EA200900817A1 (ru) Способ получения фторметилзамещённых гетероциклических соединений
RS54047B1 (en) PROCEDURE FOR OBTAINING 4-OXOCHINOLINE COMPOUNDS
ATE452882T1 (de) Herstellung von quetiapin
CY1107635T1 (el) Μεθοδος για την παρασκευη σιταλοπραμης
AR047810A1 (es) Proceso quimico
CY1106126T1 (el) Μεθοδος δια την παρασκευην ενωσεων 2-(4-αλκυλο-1-πιπepαζινυλο)-βενζαλδεϋδης και-βενζυλιδενυλιου δια νουκλεοφιλικης αρωματικης υποκαταστασεως 2-φθοροβενζαλδεϋδης δια 4-αλκυλο-1-πιπepαζινης, εις υδωρ ως διαλυτην
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
MXPA04000771A (es) Metodo para nitracion de compuestos fenolicos.
BR0214445B1 (pt) processos para a produção de compostos.
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
DE60234279D1 (de) Verfahren zur herstellung eines immunosuppresivums
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
EE05136B1 (et) Asendatud imidasopridiinhendite valmistamise meetod
BRPI0400141A (pt) Composição de incenso inseticida, e emulsão e processo para produção da mesma
FR2854402A1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
DK1497290T3 (da) Fremgangsmåde til fremstilling af syresalte af gemifloxacin
EA200300771A1 (ru) Новая соль бензоилгуанидина
MXPA05013732A (es) Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo.
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden